Virological outcomes and treatment algorithms utilisation in observational study of patients with chronic hepatitis C treated with boceprevir or telaprevir

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2036|41|7|671-685

ISSN： 0269-2813

Source： ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol.41, Iss.7, 2015-04, pp. : 671-685

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Viral kinetics analysis and virological characterization of treatment failures in patients with chronic hepatitis C treated with sofosbuvir and an NS5A inhibitor

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 47, Iss. 5, 2018-03 ,pp. : 665-673

John Wiley & Sons Inc

Access to resources Recommend Favorite

P137: Assessment of outcomes of triple combination therapy including telaprevir in treating chronic hepatitis C in hemodialysis patients

By  

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 22, Iss. S2, 2015-06 ,pp. : 88-89

John Wiley & Sons Inc

Access to resources Recommend Favorite

Work productivity among treatment‐naïve patients with genotype 1 chronic hepatitis C infection receiving telaprevir combination treatment

By  

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 22, Iss. 1, 2015-01 ,pp. : 8-17

John Wiley & Sons Inc

Access to resources Recommend Favorite

Y. S. Sakin et al.

By  

HEPATOLOGY RESEARCH, Vol. 44, Iss. 9, 2014-09 ,pp. : 1037-1037

John Wiley & Sons Inc

Access to resources Recommend Favorite

Telaprevir‐based triple therapy for chronic hepatitis C patients with advanced fibrosis: a prospective clinical study

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 38, Iss. 9, 2013-11 ,pp. : 1076-1085

John Wiley & Sons Inc

Access to resources Recommend Favorite